New Delhi, Jul 1 (PTI) Glenmark Pharmaceuticals Inc, USA, was charged for conspiring to fix prices for generic drugs, the US Department of Justice said on Tuesday.

The case, filed in the US District Court in Philadelphia, Pennsylvania, involved allegation that Glenmark conspired with Apotex Corp and other generic drug companies to increase and maintain prices of pravastatin and other generic drugs beginning in or around May 2013 and continuing until at least in or around December 2015, the Department of Justice said in a statement.

Also Read | 2020 Honda Livo BS6 Motorcycle Launched in India at Rs 69,422; Prices, Variants, Specifications, Features & Other Detail.

The charge alleges that the gain to the conspirators, and the loss to the victims, was at least USD 200 million, it added.

When asked about the charges, a Glenmark spokesperson said, "We strongly disagree with the charges being advanced by the Federal government and do not believe the evidence supports the government's case".

Also Read | Indian Railways Begins Construction of First Pillar in the Sea for Pamban Vertical Bridge in Rameswaram, Here Are all Details About 2-KM Long Sea-Bridge.

"These charges run contrary to the very essence of Glenmark -- to drive down drug prices and improve patient access to medications. We will continue to vigorously defend against these charges, and we are confident the overwhelming evidence will make that clear," the spokesperson added.

Glenmark is the fifth company to be charged over the last 13 months in connection with antitrust violations in the generic pharmaceutical industry. The previous corporate charges, including the charge against Glenmark's co-conspirator Apotex, were resolved by deferred prosecution agreement, the statement by the US Department of Justice said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)